Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma.
CONCLUSIONS: Although a trend for improved rwPFS and rwOS with newer versus older treatments was suggested, additional treatment options to improve patient outcomes are needed.
PMID: 32844683 [PubMed - as supplied by publisher]
Source: Expert Review of Hematology - Category: Hematology Tags: Expert Rev Hematol Source Type: research
More News: Anemia | Cancer & Oncology | Hematology | Myeloma | Pain | Revlimid | Statistics | Velcade